Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo

Nanotechnology

Volumn 21, Issue 47, 2010, Pages

  Sun, Minjie ^a   Wang, Yu ^a   Shen, Jie ^a   Xiao, Yanyu ^a   Su, Zhigui ^a   Ping, Qineng ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM SULFATE; BALB/C MICE; CELL APOPTOSIS; CHO CELL; CLINICAL THERAPY; CYTOTOXICTY; DOXORUBICIN; DRUG UPTAKE; EX-VIVO; IN-VITRO; IN-VIVO; INTERMEDIATE FORMATION; MELANOMA TUMORS; OCTREOTIDE; P-NITROPHENYL CARBONATES; PHOSPHATIDYLETHANOLAMINE; SOMATOSTATIN RECEPTORS; TUMOR DIAGNOSIS;

AMMONIUM COMPOUNDS; CELL DEATH; GRADIENT METHODS; LIPOSOMES; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; REACTION INTERMEDIATES;

TUMORS;

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; LIPOSOME; MACROGOL DERIVATIVE; OCTREOTIDE; PHOSPHATIDYLETHANOLAMINE; SOMATOSTATIN RECEPTOR;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CHEMISTRY; CHO CELL; CRICETULUS; DRUG EFFECT; HAMSTER; HUMAN; METABOLISM; MOUSE; NEOPLASM; TUMOR CELL LINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; DOXORUBICIN; HUMANS; LIPOSOMES; MICE; MICE, INBRED BALB C; NEOPLASMS; OCTREOTIDE; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; RECEPTORS, SOMATOSTATIN;

EID: 78650129251     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/21/47/475101     Document Type: Article

References (37)

1. Reubi J C 2003 Peptide receptors as molecular targets for cancer diagnosis and therapy Endocr. Rev. 24 389-427 (Pubitemid 37056239)
2. Hofland L J and Lamberts S W 1996 Somatostatin receptors and disease: role of receptor subtypes Baillieres Clin. Endocrinol. Metab. 10 163-76 (Pubitemid 26120312)
3. Park C et al 2004 Somatostatin (SRIF) receptor subtype 2 and 5 gene expression in growth hormone-secreting pituitary adenomas: the relationship with endogenous SRIF activity and response to octreotide Endocr. J. 51 227-36 (Pubitemid 38657560)
4. Pisarek H, Stepien T, Kubiak R and Pawlikowski M 2008 Somatostatin receptors in human adrenal gland tumors-immunohistochemical study Folia Histochem. Cytobiol. 46 345-51
5. Fjallskog M L, Ludvigsen E, Stridsberg M, Oberg K, Eriksson B and Janson E T 2003 Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors Med. Oncol. 20 59-67 (Pubitemid 36344027)
6. Reichlin S 1983 Somatostatin New Eng. J. Med. 309 1495-501
7. Osapay G et al 1997 Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies J. Med. Chem. 40 2241-51 (Pubitemid 27284362)
8. 90Y-DOTATOC in patients with neuroendocrine tumors Anticancer Res. 26 (1 B) 703-7 (Pubitemid 43206037)
9. 111In-pentetreotide therapy in patients with disseminated neuroendocrine tumors J. Nucl. Med. 44 1-6 (Pubitemid 36077704)
10. Sun M L, Wei J M, Wang X W, Li L, Wang P, Li M and Yi C H 2007 Paclitaxel-octreotide conjugates inhibit growth of human non-small cell lung cancer cells in vitro Exp. Oncol. 29 186-91 (Pubitemid 350206744)
11. Maruyama K, Takizawa T, Yuda T, Kennel S J, Huang L and Iwatsuru M 1995 Targetability of novel immunoliposomes modified with amphipathic poly (ethylene glycol) s conjugated at their distal terminals to monoclonal antibodies Biochim. Biophys. Acta 1234 74-80
12. Mercadal M, Domingo J C, Petriz J, Garcia J and Madariaga M A 2000 Preparation of immunoliposomes bearing poly (ethylene glycol)-coupled monoclonal antibody linked via a cleavable disulfide bond for ex vivo applications Biochim. Biophys. Acta 1509 299-310
13. Hansen C B, Kao G Y, Moase E H, Zalipsky S and Allen T M 1995 Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures Biochim. Biophys. Acta 1239 133-44
14. Torchilin V P, Levchenko T S, Lukyanov A N, Khaw B A, Klibanov A L, Rammohan R, Samokhin G P and Whiteman K R 2001 p-nitrophenylcarbonyl-PEG-PE- liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups Biochim. Biophys. Acta 1511 397-411 (Pubitemid 32250227)
15. Lukyanov A N, Elbayoumi T A, Chakilam A R and Torchilin V P 2004 Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody J. Control. Release 100 135-44 (Pubitemid 39445991)
16. Torchilin V P, Rammohan R, Weissig V and Levchenko T S 2001 TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors Proc. Natl Acad. Sci. USA 98 8786-91 (Pubitemid 32678105)
17. Riley A M, Laude A J, Taylor C W and Potter B V 2004 Dimers of D-myo-inositol 1, 4, 5-trisphosphate: design, synthesis, and interaction with Ins (1, 4, 5) P3 receptors Bioconjug. Chem. 15 278-89 (Pubitemid 38365187)
18. Haran G, Cohen R, Bar L K and Barenholz Y 1993 Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases Biochim. Biophys. Acta 1151 201-15 (Pubitemid 23283973)
19. Hoefnagel C A, Rankin E M, Valdés Olmos R A, Israëls S P, Pavel S and Janssen A G 1994 Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentreotide Eur. J. Nucl. Med. 21 587-8 (Pubitemid 24189422)
20. 125I-DOTA-TATE Appl. Radiat. Isot. 65 687-90 (Pubitemid 46550905)
21. Shinozawa S, Mimaki Y and Araki Y 1980 Determination of the concentration of adriamycin and its metabolites in the serum and tissues of Ehrlich carcinoma-bearing mice by high-performance liquid chromatography J. Chromatogr. 196 463-9 (Pubitemid 11228665)
22. Arnold R D, Slack J E and Straubinger R M 2004 Quantification of doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy J. Chromatogr. B 808 141-52 (Pubitemid 38952908)
23. Zhang J, Jin W, Wang X, Wang J, Zhang X and Zhang Q 2010 A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin Mol. Pharm. 7 1159-68
24. Zhang C, Tang N, Liu X, Liang W, Xu W and Torchilin V P 2006 siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene J. Control. Release 112 229-39
25. Ishida O, Maruyama K, Sasaki K and Iwatsuru M 1999 Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice Int. J. Pharm. 190 49-56 (Pubitemid 29467471)
26. Düzgünes N and Nir S 1999 Mechanisms and kinetics of liposome-cell interactions Adv. Drug Deliv. Rev. 40 3-18 (Pubitemid 29486601)
27. Lum S S, Fletcher W S, O'Dorisio M S, Nance R W, Pommier R F and Caprara M 2001 Distribution and functional significance of somatostatin receptors in malignant melanoma World J. Surg. 25 407-12 (Pubitemid 32455189)
28. Grozinsky-Glasberg S, Grossman A B and Korbonits M 2008 The role of somatostatin analogues in the treatment of neuroendocrine tumours Mol. Cell. Endocrinol. 286 238-50 (Pubitemid 351689003)
29. Wu J, Lee A, Lu Y and Lee R 2007 Vascular targeting of doxorubicin using cationic liposomes Int. J. Pharm. 337 329-35 (Pubitemid 46756051)
30. Tseng Y, Liu J and Hong R 2002 Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and Tat: a kinetic and efficacy study Mol. Pharm. 62 864-72
31. Shi G, Guo W, Stephenson S M and Lee R J 2002 Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations J. Control. Release 80 309-19 (Pubitemid 34273768)
32. Maruyama K, Takahashi N, Tagawa T, Nagaike K and Iwatsuru M 1997 Immunoliposomes bearing polyethyleneglycol-coupled fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo FEBS Lett. 413 177-80 (Pubitemid 27348659)
33. Yamada Y, Post S R, Wang K, Tager H S, Bell G I and Seino S 1992 Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney Proc. Natl Acad. Sci. USA 89 251-5
34. Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F and Schule R 1993 Cloning and characterization of a fourth human somatostatin receptor Proc. Natl Acad. Sci. USA 90 4196-200 (Pubitemid 23134193)
35. Strowski M Z and Blake A D 2008 Function and expression of somatostatin receptors of the endocrine pancreas Mol. Cell. Endocrinol. 286 169-79
36. Kimura N, Pilichowska M, Date F, Kimura I and Schindler M 1999 Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors Clin. Cancer Res. 5 3483-7
37. Chen C H, Liu D Z, Fang H W, Liang H J, Yang T S and Lin S Y 2008 Evaluation of multi-target and single-target liposomal drug for the treatment of gastric cancer Biosci. Biotechnol. Biochem. 72 1586-94